Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial
Paul Kolm(Christiana Care Health System), William S. Weintraub(Unknown), Emir Veledar(University of Miami), Yong Yuan(Kunming Medical University), Shamir R. Mehta(Population Health Research Institute), Judith A. O’Brien(Concord Consortium)
Cited by 19
Related Papers
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden
|Circulation|2008|1.6k
Complete Revascularization with Multivessel PCI for Myocardial Infarction
|New England Journal of Medicine|2019|926
Effect of PCI on Quality of Life in Patients with Stable Coronary Disease
|New England Journal of Medicine|2008|732
Treatments, Trends, and Outcomes of Acute Myocardial Infarction and Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2010|447
Sex Differences in Hospital Mortality After Coronary Artery Bypass Surgery
|Circulation|2002|399